DE3483869D1 - Zusammensetzungen zur bekaempfung von toxaemia. - Google Patents

Zusammensetzungen zur bekaempfung von toxaemia.

Info

Publication number
DE3483869D1
DE3483869D1 DE8484307227T DE3483869T DE3483869D1 DE 3483869 D1 DE3483869 D1 DE 3483869D1 DE 8484307227 T DE8484307227 T DE 8484307227T DE 3483869 T DE3483869 T DE 3483869T DE 3483869 D1 DE3483869 D1 DE 3483869D1
Authority
DE
Germany
Prior art keywords
sup
combat
compositions
toxaemia
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8484307227T
Other languages
English (en)
Inventor
Rolf Wilhelm Pfirrmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ed Geistlich Soehne AG fuer Chemische Industrie
Original Assignee
Ed Geistlich Soehne AG fuer Chemische Industrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ed Geistlich Soehne AG fuer Chemische Industrie filed Critical Ed Geistlich Soehne AG fuer Chemische Industrie
Application granted granted Critical
Publication of DE3483869D1 publication Critical patent/DE3483869D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE8484307227T 1983-10-20 1984-10-19 Zusammensetzungen zur bekaempfung von toxaemia. Expired - Fee Related DE3483869D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838328111A GB8328111D0 (en) 1983-10-20 1983-10-20 Chemical compounds

Publications (1)

Publication Number Publication Date
DE3483869D1 true DE3483869D1 (de) 1991-02-07

Family

ID=10550511

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8484307227T Expired - Fee Related DE3483869D1 (de) 1983-10-20 1984-10-19 Zusammensetzungen zur bekaempfung von toxaemia.
DE19843438469 Withdrawn DE3438469A1 (de) 1983-10-20 1984-10-19 Mittel zur bekaempfung von toxaemie

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19843438469 Withdrawn DE3438469A1 (de) 1983-10-20 1984-10-19 Mittel zur bekaempfung von toxaemie

Country Status (10)

Country Link
US (1) US4626536A (de)
EP (1) EP0139535B1 (de)
JP (1) JPS60105618A (de)
AT (1) ATE59296T1 (de)
AU (1) AU3457384A (de)
BE (1) BE900856A (de)
CH (1) CH660970A5 (de)
DE (2) DE3483869D1 (de)
GB (1) GB8328111D0 (de)
IT (1) IT1178154B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
GB8617482D0 (en) * 1986-07-17 1986-08-28 Geistlich Soehne Ag Pharmaceutical composition
GB9005856D0 (en) * 1990-03-15 1990-05-09 Geistlich Soehne Ag Compositions
GB9600426D0 (en) * 1996-01-10 1996-03-13 Ed Geistlich Sohne A G Compositions
US20050124608A1 (en) * 2001-04-03 2005-06-09 Redmond H. P. Treatment of cancers
US8304390B2 (en) 1997-07-31 2012-11-06 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method of treatment for preventing or reducing tumor growth in the liver of patient
US20060199811A1 (en) * 1997-07-31 2006-09-07 Pfirrmann Rolf W Method of treatment for preventing or reducing tumor growth in the liver of patient
US6479481B1 (en) * 1999-06-04 2002-11-12 Ed. Geistlich Soehne Ag Fur Chemische Industrie Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
US6011030A (en) * 1997-09-22 2000-01-04 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating symptoms of microbial infection or sepsis
US5972933A (en) * 1998-01-08 1999-10-26 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating microbial infections
US6166007A (en) 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
US8030301B2 (en) 1999-06-04 2011-10-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of cancers with methylol-containing compounds and at least one electrolyte
US7345039B2 (en) 1999-06-04 2008-03-18 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
US7892530B2 (en) 1999-06-04 2011-02-22 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of tumor metastases and cancer
US6821968B2 (en) * 2001-09-26 2004-11-23 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Stable taurolidine electrolyte solutions
US6685694B2 (en) 1999-07-23 2004-02-03 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6679870B1 (en) 1999-07-23 2004-01-20 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
JP3213293B2 (ja) 1999-08-02 2001-10-02 本田技研工業株式会社 エンジン制御装置
EP1248625A2 (de) * 1999-12-06 2002-10-16 Rhode Island Hospital Verwendung von methylol-enthaltenden verbindungen zur herstellung eines medikaments zur behandlung von tumoren
CN100519525C (zh) * 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
US6641571B2 (en) * 2000-01-05 2003-11-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery
US20020004502A1 (en) * 2000-01-05 2002-01-10 Redmond H. Paul Treatment of inflammatory bowel disease
EP1245247A1 (de) 2001-03-28 2002-10-02 Biolink Corporation Biozidschleuse
US20080171738A1 (en) * 2001-04-03 2008-07-17 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of Breast Cancer
CA2462564C (en) 2001-10-01 2012-07-10 Rhode Island Hospital Methods of inhibiting metastases
US20050008684A1 (en) * 2003-07-10 2005-01-13 Claus Herdeis Method of treatment for acne, rosacea and ulcers with taurolidine and/or taurultam in a pharmaceutical composition
US20080177217A1 (en) * 2004-05-14 2008-07-24 Hans-Dietrich Polaschegg Taurolidine Formulations and Delivery: Therapeutic Treatments and Antimicrobial Protection Against Bacterial Biofilm Formation
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
RU2624846C1 (ru) * 2016-10-10 2017-07-07 федеральное государственное бюджетное учреждение "Федеральный научно-исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации Применение 4-(3-этокси-4-гидроксибензил)-5-оксо-5,6-дигидро-4Н-[1,3,4]-тиадиазин-2-(2,4-дифторфенил)-карбоксамида для подавления инфекции, вызванной устойчивыми к антибиотикам штаммами Pseudomonas aeruginosa, и способ подавления этой инфекции
RU2737087C1 (ru) * 2020-03-20 2020-11-24 федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации Фармацевтическая композиция 4-(3-этокси-4-гидроксибензил)-5-оксо-5,6-дигидро-4h-[1,3,4]-тиадиазин-2-(2,4-дифторфенил)"карбоксамид в кристаллической форме, и ее применение в качестве антибактериального препарата для лечения острых, рецидивирующих и хронических инфекций
US11738120B1 (en) 2022-04-14 2023-08-29 Cormedix Inc. Synthesis of taurolidine, purity profiles and polymorphs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107305A (en) * 1975-08-04 1978-08-15 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Treatment of endotoxaemia
GB1525296A (en) * 1975-08-04 1978-09-20 Geistlich Soehne Ag Antibacterial compositions

Also Published As

Publication number Publication date
AU3457384A (en) 1986-04-24
ATE59296T1 (de) 1991-01-15
IT8449031A1 (it) 1986-04-18
BE900856A (fr) 1985-02-15
IT8449031A0 (it) 1984-10-18
EP0139535A2 (de) 1985-05-02
CH660970A5 (de) 1987-06-30
EP0139535A3 (en) 1985-10-23
JPS60105618A (ja) 1985-06-11
US4626536A (en) 1986-12-02
EP0139535B1 (de) 1990-12-27
IT1178154B (it) 1987-09-09
DE3438469A1 (de) 1985-05-09
GB8328111D0 (en) 1983-11-23

Similar Documents

Publication Publication Date Title
DE3483869D1 (de) Zusammensetzungen zur bekaempfung von toxaemia.
ES2065880T3 (es) Proteina quimicamente modificada y obtencion de la misma.
DE3486150D1 (de) Zusammensetzungen zur propylaktischen behandlung von osteitis und osteomyelitis.
DE59002863D1 (de) Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
ES8505374A1 (es) Un procedimiento para la preparacion de un derivado de cefalosporina
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
AU1395283A (en) 1-carboxyalkanoylindoline-2-carboxylic acid esters
GR3035205T3 (en) Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof
ES8306994A1 (es) Procedimiento para la obtencion de diamidas de acido hidroxi-maloico sustituidas.
ES8300094A1 (es) "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
AU557068B2 (en) 1-aroyl-5-oxo-2-pyrrolidine propanoic acids and esters
DE59107456D1 (de) Verwendung von Phosphonsäurediglycidylestern als Vernetzer bei Hydrogelen
KR910006217A (ko) 디히드로카페인산 유도체 및 이를 함유하는 약학제제
ATE33139T1 (de) Oximinophosphorsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen.
KR840000235A (ko) 치환 히드록시벤젠류에 의한 2-레노일메르캅토프로피온일글리신의 에스테르 제조방법 및 이를 함유한 약제조성물
ES8502990A1 (es) Procedimiento para preparar derivados de (x)-cianidan-3-ol.
DK602083A (da) 4-hydroxybenzhydroler
EP0086756A3 (de) Dermatologische Mittel die auf Thiolester der Merkaptopropionylamidoessigsäure basieren
IE880226L (en) 2-(2,2-difluorocyclopropyl) alkyl esters
TH2281EX (th) สารประกอบฟอสฟอโรไดไธโออิคที่ใช้ฆ่าตัวรังควาน
KR900003162A (ko) 비스(메틸렌디옥시)비페닐 화합물
WO1987003596A3 (fr) Nouveaux composes phosphores et medicaments les contenant

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee